Allogene Therapeutics, Inc. Shares Outstanding (Cover Page)
Allogene Therapeutics, Inc. (ALLO) had Shares Outstanding (Cover Page) of 345.49 million shares as of 2026-08-10, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-10: Entity Common Stock, Shares Outstanding 345.49M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 345.15M shares.
- 2026-03-10: Entity Common Stock, Shares Outstanding 243.78M shares.
- 2025-11-04: Entity Common Stock, Shares Outstanding 224.73M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 345.49M shares 10-Q · filed 2026-08-12 |
| 2026-05-11 | 345.15M shares 10-Q · filed 2026-05-13 |
| 2026-03-10 | 243.78M shares 10-K · filed 2026-03-12 |
| 2025-11-04 | 224.73M shares 10-Q · filed 2025-11-06 |
| 2025-08-11 | 221.88M shares 10-Q · filed 2025-08-13 |
| 2025-05-09 | 218.73M shares 10-Q · filed 2025-05-13 |
| 2025-03-07 | 217.26M shares 10-K · filed 2025-03-13 |
| 2024-11-01 | 209.67M shares 10-Q · filed 2024-11-07 |
| 2024-08-02 | 209.11M shares 10-Q · filed 2024-08-07 |
| 2024-05-09 | 170.85M shares 10-Q · filed 2024-05-13 |
| 2024-03-12 | 169.09M shares 10-K · filed 2024-03-14 |
| 2023-10-31 | 168.28M shares 10-Q · filed 2023-11-02 |
| 2023-07-31 | 167.63M shares 10-Q · filed 2023-08-02 |
| 2023-05-01 | 145.84M shares 10-Q · filed 2023-05-03 |
| 2023-02-24 | 144.50M shares 10-K/A · filed 2024-03-14 |
| 2022-10-31 | 144.21M shares 10-Q · filed 2022-11-02 |
| 2022-08-05 | 143.81M shares 10-Q · filed 2022-08-09 |
| 2022-05-02 | 143.60M shares 10-Q · filed 2022-05-04 |
| 2022-02-21 | 142.75M shares 10-K · filed 2022-02-23 |
| 2021-11-02 | 142.52M shares 10-Q · filed 2021-11-04 |
| 2021-08-02 | 142.18M shares 10-Q · filed 2021-08-04 |
| 2021-05-03 | 141.54M shares 10-Q · filed 2021-05-05 |
| 2021-02-22 | 140.65M shares 10-K · filed 2021-02-25 |
| 2020-11-02 | 140.28M shares 10-Q · filed 2020-11-04 |
| 2020-08-03 | 139.29M shares 10-Q · filed 2020-08-05 |
| 2020-05-04 | 125.33M shares 10-Q · filed 2020-05-06 |
| 2020-02-24 | 124.91M shares 10-K · filed 2020-02-27 |
| 2019-11-01 | 121.90M shares 10-Q · filed 2019-11-05 |
| 2019-08-02 | 121.75M shares 10-Q · filed 2019-08-07 |
| 2019-05-03 | 121.54M shares 10-Q · filed 2019-05-07 |
| 2019-03-04 | 121.48M shares 10-K · filed 2019-03-08 |
| 2018-11-15 | 121.48M shares 10-Q · filed 2018-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |